AI model predicts B cell reactivity to neoantigens for improved cancer vaccines

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move beyond one-time attacks and short-term memory to become a long-term immunity that "remembers" cancer, effectively preventing recurrence. KAIST's research team has developed an AI-based personalized cancer vaccine design technology that makes this possible and optimizes anticancer effects for each individual.

Costs pose hurdle for promising new hepatitis C lab test

A new rapid test for hepatitis C could help identify many more patients who could be cured of the deadly disease, but its use may be limited unless insurers' reimbursement rises to cover its high cost, according to researchers from the University of Washington School of Medicine in Seattle.

Creating cells that help the brain keep its cool

Researchers at Lund University in Sweden have created a method that makes it possible to transform the brain's support cells into parvalbumin-positive cells. These cells act as the brain's rapid-braking system and are significantly involved in schizophrenia, epilepsy and other neurological conditions.